All In Biotech

Drug Trial Radar · NCT00337675

Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)

A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study Evaluating the Effects of 2 Different Regimens of Montelukast (Daily Dosing and Intermittent, Episode-Driven Dosing) Compared With Placebo in the Treatment of Episodic Asthma in Children Aged 6 Months to 5 Years

Last checked: Nov 19, 2026Latest source record: May 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,771 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,771

Actual

Start

Oct 2006

Primary completion

Aug 2009

Study completion Aug 2009

Sponsor

Lead sponsor
Organon and CoIndustry
Sponsor type
Industry
First posted
Jun 16, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 6 months, up to 5 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a year-long study evaluating the efficacy of both daily and intermittent treatment of asthma in children who experience symptoms episodically (i.e., seasonally, usually in the context of upper respiratory tract infection).

Conditions

  • Asthma

Interventions

  • montelukast sodiumDrug

    Montelukast 4 mg (or 5 mg, depending on age of patient) qd + episode driven supplemental Pbo qd for 12 days for a 52-wk treatment period.

  • Comparator: Placebo (unspecified)Drug

    Placebo (Pbo) qd + episode driven supplemental Pbo for 12 days for a 52-wk treatment period.

  • montelukast sodiumDrug

    Pbo qd + episode driven supplemental Montelukast 4 mg (or 5 mg, depending on age of patient) qd for 12 days for a 52-wk treatment period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Asthma Episodes Culminating in Asthma Attack Over the 1-year Treatment PeriodTime frame: 1-year treatment period

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.